Rock Springs Capital Management’s RAPT Therapeutics RAPT Stock Holding History

Rock Springs Capital Management’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-213,731	Closed	-$7.24M	–	106
2025 Q4	$7.24M	Buy	+213,731	New	+$6.64M	0.37%	60

Rock Springs Capital Management's RAPT Position: Q1 2026 in Review

Rock Springs Capital Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 213,731 shares — an estimated $7.24M sold.

Rock Springs Capital Management first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $7.24M in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Rock Springs Capital Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Rock Springs Capital Management sold 213,731 RAPT Therapeutics shares in Q1 2026, an estimated $7.24M.
Rock Springs Capital Management first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
Rock Springs Capital Management's RAPT Therapeutics position peaked at $7.24M in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Rock Springs Capital Management's 13F filing for Q1 2026, filed 15 May 2026.